Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures
US-9757463-B2 · Sep 12, 2017 · US
US10308763B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10308763-B2 |
| Application number | US-201715684638-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 23, 2017 |
| Priority date | Jan 24, 2014 |
| Publication date | Jun 4, 2019 |
| Grant date | Jun 4, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for a variety of applications, including, but not limited to, drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Opening claim text (preview).
What is claimed is: 1. A polymer comprising repeating units selected from and repeating units selected from wherein R 0 is selected from H, alkyl, NH 2 , and R 1 ; wherein R 1 comprises a crosslinking functionality; wherein repeating units A1, A2, B1, and B2 account for at least about 50 wgt % of the polymer; wherein the ratio of (A1+A2):(B1+B2) is greater than 1; and wherein the polymer does not comprise a moiety; and wherein the polymer is crosslinked. 2. The polymer of claim 1 , wherein the polymer comprises 0 wgt % of a repeating unit formed from tetrahydrofuran. 3. The polymer of claim 1 , wherein the ratio of (A1+A2):(B1+B2) is from about 1.5 to about 10.0. 4. A polymer comprising repeating units selected from and repeating units selected from wherein R 0 is selected from H, alkyl, NH 2 , and R 1 ; wherein R 1 comprises a crosslinking functionality; wherein repeating units A1, A2, B1, and B2 account for at least about 50 wgt % of the polymer; wherein the ratio of (A1+A2):(B1+B2) is greater than 1; and wherein the polymer does not comprise a moiety; and wherein repeating units A1, A2, B1 and B2 account for at least about 100 wgt% of the polymer. 5. The polymer of claim 1 , wherein the polymer further comprises at least one repeating unit formed from a monomer selected from: or a combination thereof. 6. The polymer of claim 1 , wherein the polymer has a weight average molecular weight from about 0.3 kDa to about 40 kDa. 7. A polymer comprising repeating units selected from and repeating units selected from wherein R 0 is selected from H, alkyl, NH 2 , and R 1 ; wherein R 1 comprises a crosslinking functionality; wherein repeating units A1, A2, B1, and B2 account for at least about 50 wgt % of the polymer; wherein the ratio of (A1+A2):(B1+B2) is greater than 1; and wherein the polymer does not comprise a moiety; and wherein the polymer does not comprise a unit or repeating unit formed from diglycidyl ether. 8. A polymer comprising repeating units selected from and repeating units selected from wherein R 0 is selected from H, alkyl, NH 2 , and R 1 ; wherein R 1 comprises a crosslinking functionality; wherein repeating units A1, A2, B1, and B2 account for at least about 50 wgt % of the polymer; wherein the ratio of (A1+A2):(B1+B2) is greater than 1; and wherein the polymer does not comprise a moiety, and wherein the polymer does not comprise an initiator other than glycidol. 9. The polymer of claim 1 , wherein the polymer does not comprise a metal catalyst residue. 10. The polymer of claim 9 , wherein the metal catalyst residue is a tin catalyst residue. 11. The polymer of claim 1 , wherein the degree of branching is between 0.15 and 0.30. 12. The polymer of claim 1 , wherein the degree of branching is between 0.20 and 0.30. 13. The polymer of claim 1 , wherein the polymer is further conjugated to a protein. 14. The polymer of claim 13 , wherein the protein is albumin. 15. The polymer of claim 1 , wherein the polymer includes crosslinkers that comprise wherein at least one of is not 0. 16. The polymer of claim 1 , wherein the polymer comprises 17. A pharmaceutical composition comprising a polymer of claim 1 and a pharmaceutically acceptable carrier. 18. The pharmaceutical composition of claim 17 , wherein the pharmaceutical composition further comprises a pharmaceutically active agent or a biologically active agent. 19. A nanoparticle comprising a polymer of claim 1 .
Polymeric initiators · CPC title
from hydroxy compounds or their metallic derivatives {(C08G65/26 takes precedence)} · CPC title
Polyhydroxyethers, e.g. phenoxy resins · CPC title
Cyclic ethers having at least one atom other than carbon and hydrogen outside the ring · CPC title
containing oxygen in addition to the ether group · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.